SCHEMBL6193578

SCHEMBL6193578

Clc1ccc2c(c1)NC(CBr)CC2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CMA1 P23946 1/20 0.39
▸ AHR P35869 1/20 0.39
▸ HTR2A P28223 6/20 0.38
▸ HTR2C P28335 6/20 0.38
▸ HTR2B P41595 6/20 0.38
▸ MTNR1A P48039 3/20 0.38
▸ SRD5A1 P18405 2/20 0.37
▸ PNMT P11086 1/20 0.36
▸ HTR3E A5X5Y0 1/20 0.36
▸ HTR3B O95264 1/20 0.36
▸ HTR3A P46098 1/20 0.36
▸ HTR3D Q70Z44 1/20 0.36
▸ HTR3C Q8WXA8 1/20 0.36
▸ HTR5A P47898 1/20 0.35
▸ ADRB1 P08588 1/20 0.35
▸ HTR1A P08908 1/20 0.35
▸ ADRA2A P08913 1/20 0.35
▸ ADRA2B P18089 1/20 0.35
▸ ADRA2C P18825 1/20 0.35
▸ CNR1 P21554 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28618675 0.75 HTR2C (0.44) CMA1AHRHTR2AHTR2CHTR2B
SCHEMBL10841342 0.73 AR (0.43) AHRHTR2AHTR2CHTR2BMTNR1A
SCHEMBL6196313 0.73 ESR1 (0.39) AHRHTR2AHTR2CHTR2BMTNR1A
SCHEMBL6194447 0.73 TRPM5 (0.43) AHRHTR2AHTR2CHTR2BMTNR1A
SCHEMBL13634392 0.70 ADRA2A (0.46) CMA1AHRHTR2AHTR2CHTR2B
SCHEMBL30542586 0.70 GAA (0.51) CMA1AHRHTR2AHTR2CGRIN2B
SCHEMBL4763545 0.69 ITGB3 (0.40) AHRMTNR1ASRD5A1IDO1GRIN2B
SCHEMBL166021 0.69 HTR2C (0.41) CMA1AHRHTR2AHTR2CHTR2B
SCHEMBL6956357 0.69 AHR (0.59) CMA1AHRHTR2AHTR2CHTR2B
SCHEMBL17634157 0.68 MTNR1A (0.46) MTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432701-B1 HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF DISORDERS OF THE URINARY TRACT RECORDATI IRELAND LTD (IE) 2005-12-21 — — EP disclosed
EP-1432701-A1 HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF DISORDERS OF THE URINARY TRACT RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY (CH) 2004-06-30 — — EP disclosed
WO-2003031436-A1 HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF DISORDERS OF THE URINARY TRACT RECORDATI S.A. (CH) 2003-04-17 — — WO disclosed
Send feedback